Work

Abstract B117: Discovery of potent, selective, and orally bioavailable heterobifunctional EP300 degraders

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b117

Authors: Yongtaek Lee, Sun Young Jang, SeokJong Kang, Ho Yeon Nam, Seongil Kang, Taegun Kim, Gunwoo Lee, Wonjong Lee, Hobin Im, Boram Kim, Yu-Yon Kim, Jooyun Byun, Haemin Chon, Young Gil Ahn

Institution: Hanmi Pharmaceutical (South Korea)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415449573

Cites:

Cited by:

Related to: